Deband: Difference between revisions

From Ephinea PSO Wiki
m (Categorizing)
Line 41: Line 41:
! rowspan="2" | TP <br />Cost
! rowspan="2" | TP <br />Cost
! rowspan="2" | MST <br />Required<br />To Learn
! rowspan="2" | MST <br />Required<br />To Learn
! rowspan="2" |Duration
In
seconds
! colspan="2" | Targeting Range
! colspan="2" | Targeting Range
! colspan="2" | Targeting Angle
! colspan="2" | Targeting Angle
Line 53: Line 56:
| style="vertical-align:middle; background-color:#C9DAF8;" | 10
| style="vertical-align:middle; background-color:#C9DAF8;" | 10
| style="vertical-align:middle; background-color:#D9D2E9;" | 60
| style="vertical-align:middle; background-color:#D9D2E9;" | 60
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 62: Line 66:
| style="vertical-align:middle; background-color:#C9DAF8;" | 11
| style="vertical-align:middle; background-color:#C9DAF8;" | 11
| style="vertical-align:middle; background-color:#D9D2E9;" | 88
| style="vertical-align:middle; background-color:#D9D2E9;" | 88
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 71: Line 76:
| style="vertical-align:middle; background-color:#C9DAF8;" | 12
| style="vertical-align:middle; background-color:#C9DAF8;" | 12
| style="vertical-align:middle; background-color:#D9D2E9;" | 116
| style="vertical-align:middle; background-color:#D9D2E9;" | 116
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 80: Line 86:
| style="vertical-align:middle; background-color:#C9DAF8;" | 13
| style="vertical-align:middle; background-color:#C9DAF8;" | 13
| style="vertical-align:middle; background-color:#D9D2E9;" | 144
| style="vertical-align:middle; background-color:#D9D2E9;" | 144
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 89: Line 96:
| style="vertical-align:middle; background-color:#C9DAF8;" | 14
| style="vertical-align:middle; background-color:#C9DAF8;" | 14
| style="vertical-align:middle; background-color:#D9D2E9;" | 172
| style="vertical-align:middle; background-color:#D9D2E9;" | 172
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 98: Line 106:
| style="vertical-align:middle; background-color:#C9DAF8;" | 15
| style="vertical-align:middle; background-color:#C9DAF8;" | 15
| style="vertical-align:middle; background-color:#D9D2E9;" | 200
| style="vertical-align:middle; background-color:#D9D2E9;" | 200
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 107: Line 116:
| style="vertical-align:middle; background-color:#C9DAF8;" | 16
| style="vertical-align:middle; background-color:#C9DAF8;" | 16
| style="vertical-align:middle; background-color:#D9D2E9;" | 228
| style="vertical-align:middle; background-color:#D9D2E9;" | 228
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 116: Line 126:
| style="vertical-align:middle; background-color:#C9DAF8;" | 17
| style="vertical-align:middle; background-color:#C9DAF8;" | 17
| style="vertical-align:middle; background-color:#D9D2E9;" | 256
| style="vertical-align:middle; background-color:#D9D2E9;" | 256
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 125: Line 136:
| style="vertical-align:middle; background-color:#C9DAF8;" | 18
| style="vertical-align:middle; background-color:#C9DAF8;" | 18
| style="vertical-align:middle; background-color:#D9D2E9;" | 284
| style="vertical-align:middle; background-color:#D9D2E9;" | 284
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 134: Line 146:
| style="vertical-align:middle; background-color:#C9DAF8;" | 19
| style="vertical-align:middle; background-color:#C9DAF8;" | 19
| style="vertical-align:middle; background-color:#D9D2E9;" | 312
| style="vertical-align:middle; background-color:#D9D2E9;" | 312
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 143: Line 156:
| style="vertical-align:middle; background-color:#C9DAF8;" | 20
| style="vertical-align:middle; background-color:#C9DAF8;" | 20
| style="vertical-align:middle; background-color:#D9D2E9;" | 340
| style="vertical-align:middle; background-color:#D9D2E9;" | 340
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 152: Line 166:
| style="vertical-align:middle; background-color:#C9DAF8;" | 21
| style="vertical-align:middle; background-color:#C9DAF8;" | 21
| style="vertical-align:middle; background-color:#D9D2E9;" | 368
| style="vertical-align:middle; background-color:#D9D2E9;" | 368
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 161: Line 176:
| style="vertical-align:middle; background-color:#C9DAF8;" | 22
| style="vertical-align:middle; background-color:#C9DAF8;" | 22
| style="vertical-align:middle; background-color:#D9D2E9;" | 396
| style="vertical-align:middle; background-color:#D9D2E9;" | 396
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 170: Line 186:
| style="vertical-align:middle; background-color:#C9DAF8;" | 23
| style="vertical-align:middle; background-color:#C9DAF8;" | 23
| style="vertical-align:middle; background-color:#D9D2E9;" | 424
| style="vertical-align:middle; background-color:#D9D2E9;" | 424
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 179: Line 196:
| style="vertical-align:middle; background-color:#C9DAF8;" | 24
| style="vertical-align:middle; background-color:#C9DAF8;" | 24
| style="vertical-align:middle; background-color:#D9D2E9;" | 452
| style="vertical-align:middle; background-color:#D9D2E9;" | 452
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 188: Line 206:
| style="vertical-align:middle; background-color:#C9DAF8;" | 25
| style="vertical-align:middle; background-color:#C9DAF8;" | 25
| style="vertical-align:middle; background-color:#D9D2E9;" | 480
| style="vertical-align:middle; background-color:#D9D2E9;" | 480
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 197: Line 216:
| style="vertical-align:middle; background-color:#C9DAF8;" | 26
| style="vertical-align:middle; background-color:#C9DAF8;" | 26
| style="vertical-align:middle; background-color:#D9D2E9;" | 508
| style="vertical-align:middle; background-color:#D9D2E9;" | 508
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 206: Line 226:
| style="vertical-align:middle; background-color:#C9DAF8;" | 27
| style="vertical-align:middle; background-color:#C9DAF8;" | 27
| style="vertical-align:middle; background-color:#D9D2E9;" | 536
| style="vertical-align:middle; background-color:#D9D2E9;" | 536
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 215: Line 236:
| style="vertical-align:middle; background-color:#C9DAF8;" | 28
| style="vertical-align:middle; background-color:#C9DAF8;" | 28
| style="vertical-align:middle; background-color:#D9D2E9;" | 564
| style="vertical-align:middle; background-color:#D9D2E9;" | 564
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 224: Line 246:
| style="vertical-align:middle; background-color:#C9DAF8;" | 29
| style="vertical-align:middle; background-color:#C9DAF8;" | 29
| style="vertical-align:middle; background-color:#D9D2E9;" | 592
| style="vertical-align:middle; background-color:#D9D2E9;" | 592
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 233: Line 256:
| style="vertical-align:middle; background-color:#C9DAF8;" | 30
| style="vertical-align:middle; background-color:#C9DAF8;" | 30
| style="vertical-align:middle; background-color:#D9D2E9;" | 620
| style="vertical-align:middle; background-color:#D9D2E9;" | 620
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 242: Line 266:
| style="vertical-align:middle; background-color:#C9DAF8;" | 31
| style="vertical-align:middle; background-color:#C9DAF8;" | 31
| style="vertical-align:middle; background-color:#D9D2E9;" | 648
| style="vertical-align:middle; background-color:#D9D2E9;" | 648
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 251: Line 276:
| style="vertical-align:middle; background-color:#C9DAF8;" | 32
| style="vertical-align:middle; background-color:#C9DAF8;" | 32
| style="vertical-align:middle; background-color:#D9D2E9;" | 676
| style="vertical-align:middle; background-color:#D9D2E9;" | 676
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 260: Line 286:
| style="vertical-align:middle; background-color:#C9DAF8;" | 33
| style="vertical-align:middle; background-color:#C9DAF8;" | 33
| style="vertical-align:middle; background-color:#D9D2E9;" | 704
| style="vertical-align:middle; background-color:#D9D2E9;" | 704
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 269: Line 296:
| style="vertical-align:middle; background-color:#C9DAF8;" | 34
| style="vertical-align:middle; background-color:#C9DAF8;" | 34
| style="vertical-align:middle; background-color:#D9D2E9;" | 732
| style="vertical-align:middle; background-color:#D9D2E9;" | 732
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 278: Line 306:
| style="vertical-align:middle; background-color:#C9DAF8;" | 35
| style="vertical-align:middle; background-color:#C9DAF8;" | 35
| style="vertical-align:middle; background-color:#D9D2E9;" | 760
| style="vertical-align:middle; background-color:#D9D2E9;" | 760
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 287: Line 316:
| style="vertical-align:middle; background-color:#C9DAF8;" | 36
| style="vertical-align:middle; background-color:#C9DAF8;" | 36
| style="vertical-align:middle; background-color:#D9D2E9;" | 788
| style="vertical-align:middle; background-color:#D9D2E9;" | 788
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 296: Line 326:
| style="vertical-align:middle; background-color:#C9DAF8;" | 37
| style="vertical-align:middle; background-color:#C9DAF8;" | 37
| style="vertical-align:middle; background-color:#D9D2E9;" | 816
| style="vertical-align:middle; background-color:#D9D2E9;" | 816
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 305: Line 336:
| style="vertical-align:middle; background-color:#C9DAF8;" | 38
| style="vertical-align:middle; background-color:#C9DAF8;" | 38
| style="vertical-align:middle; background-color:#D9D2E9;" | 844
| style="vertical-align:middle; background-color:#D9D2E9;" | 844
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
Line 314: Line 346:
| style="vertical-align:middle; background-color:#C9DAF8;" | 39
| style="vertical-align:middle; background-color:#C9DAF8;" | 39
| style="vertical-align:middle; background-color:#D9D2E9;" | 872
| style="vertical-align:middle; background-color:#D9D2E9;" | 872
|
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?
| style="background-color:#fff2cc;" | ?

Revision as of 12:04, 13 March 2023

Disk icon.pngDeband
デバンド
Deband
A defensive boost technique.
Helps teammates as well, at higher levels.
Type
:
Support
HUmrHUnlHUctHUcl
× 20 ××
RAmrRAmlRActRAcl
15 20 ××
FOmrFOmlFOnmFOnl
30 30 30 30

Deband.png Deband is a support Technique that raises the DFP of the user and their allies. It improves DFP by a percentage that increases with its level.

From level 3 onward, it can also affect other nearby allies. Its duration and range also improves with its level.

Details

Boosting Equipment

The following items, when equipped, will improve Deband's range.

Weapons

Barriers

Level Progression

Deband.pngDeband's statistics improve when its level increases, but the MST required to learn it and TP required to cast it increase as well.

Lv DFP
Boost
(%)
TP
Cost
MST
Required
To Learn
Duration

In seconds

Targeting Range Targeting Angle
Horizontal Vertical Horizontal Vertical
1 10 10 60 ? ? ? ?
2 11.3 11 88 ? ? ? ?
3 12.6 12 116 ? ? ? ?
4 13.9 13 144 ? ? ? ?
5 15.2 14 172 ? ? ? ?
6 16.5 15 200 ? ? ? ?
7 17.8 16 228 ? ? ? ?
8 18.1 17 256 ? ? ? ?
9 20.4 18 284 ? ? ? ?
10 21.7 19 312 ? ? ? ?
11 23 20 340 ? ? ? ?
12 24.3 21 368 ? ? ? ?
13 25.6 22 396 ? ? ? ?
14 26.9 23 424 ? ? ? ?
15 28.2 24 452 ? ? ? ?
16 29.5 25 480 ? ? ? ?
17 30.8 26 508 ? ? ? ?
18 32.1 27 536 ? ? ? ?
19 33.4 28 564 ? ? ? ?
20 34.7 29 592 ? ? ? ?
21 36 30 620 ? ? ? ?
22 37.3 31 648 ? ? ? ?
23 38.6 32 676 ? ? ? ?
24 39.9 33 704 ? ? ? ?
25 41.2 34 732 ? ? ? ?
26 42.5 35 760 ? ? ? ?
27 43.8 36 788 ? ? ? ?
28 45.1 37 816 ? ? ? ?
29 46.4 38 844 ? ? ? ?
30 47.7 39 872 ? ? ? ?